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Introduction: Inflammatory destructive arthritis, like rheumatoid arthritis (RA), is characterized by invasion of
synovial fibroblasts (SF) into the articular cartilage and erosion of the underlying bone, leading to progressive
joint destruction. Because fibroblast activation protein alpha (FAP) has been associated with cell migration and
cell invasiveness, we studied the function of FAP in joint destruction in RA.
Methods: Expression of FAP in synovial tissues and fibroblasts from patients with osteoarthritis (OA) and RA as well as
from wild-type and arthritic mice was evaluated by immunohistochemistry, fluorescence microscopy and polymerase
chain reaction (PCR). Fibroblast adhesion and migration capacity was assessed using cartilage attachment assays
and wound-healing assays, respectively. For in vivo studies, FAP-deficient mice were crossed into the human tumor
necrosis factor transgenic mice (hTNFtg), which develop a chronic inflammatory arthritis. Beside clinical assessment,
inflammation, cartilage damage, and bone erosion were evaluated by histomorphometric analyses.
Results: RA synovial tissues demonstrated high expression of FAP whereas in OA samples only marginal expression
was detectable. Consistently, a higher expression was detected in arthritis SF compared to non-arthritis OA SF in vitro.
FAP-deficiency in hTNFtg mice led to less cartilage degradation despite unaltered inflammation and bone erosion.
Accordingly, FAP−/− hTNFtg SF demonstrated a lower cartilage adhesion capacity compared to hTNFtg SF in vitro.
Conclusions: These data point to a so far unknown role of FAP in the attachment of SF to cartilage, promoting
proteoglycan loss and subsequently cartilage degradation in chronic inflammatory arthritis.Introduction
Rheumatoid arthritis (RA) is an autoimmune disease
that primarily affects the joints and that is characterized
by chronic inflammation and progressive cartilage and
bone destruction [1]. Synovial inflammation and hyper-
plasia as well as invasion of synovial fibroblasts (SF) into
the articular cartilage and erosion of the underlying bone,
all are hallmarks of RA [2]. The major classes of proteo-
lytic enzymes implicated in the degradation of cartilage
are metalloproteinases (matrixmetalloproteinase (MMP),
a disintegrin and metalloproteinase with thrombospondin
motifs (ADAMTS)) and serine proteases [3,4]. Among the* Correspondence: dankbarb@uni-muenster.de
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unless otherwise stated.latter, fibroblast activation protein alpha (FAP) is a trans-
membrane serine protease with dual proteolytic activity, a
dipeptidyl peptidase activity and a gelantinolytic activity
[4]. Moreover, FAP is associated with cell migration and
cell invasiveness [5,6] and has been linked to several
diseases, including cancer and arthritis [6-9]. FAP is
expressed in the rheumatoid synovium [9] and has been
localized at the invadopodia of migrating lung fibroblasts
[5]. Moreover, increased formation of invadopodia by
synovial fibroblasts (SF) has recently been demonstrated
to promote cartilage breakdown in a collagen-induced
arthritis mouse model [10]. Although the proteolytic
activity of FAP has been clearly linked to migration and
invasion, the role of FAP in inflammatory matrix deg-
radation remains controversial, since inhibition of both
the proteolytic activity of FAP and dipeptidylpeptidase 4
(DPP4) showed increased cartilage invasion by rheumatoidl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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the in vivo role of FAP in joint destruction in a human
tumor necrosis factor (TNF) transgenic (hTNFtg) mouse




To assess the impact of FAP deficiency on TNF-mediated
joint destruction, fap−/− (FAP knockout) hTNFtg animals
were generated by crossing hTNFtg mice (Tg197 strain;
C57BL/6), which develop an inflammatory destructive
arthritis animals [12] with fap−/− mice (C57BL/6). Clinical
signs of arthritis were determined once weekly as described
previously [13]. The local ethics committee ‘Landesamt
für Natur, Umwelt und Verbraucherschutz Nordrhein-
Westfalen (LANUV)’ approved all animal procedures.
Histomorphometric analysis
Hind paws at week 12 were fixed overnight in 4.0% for-
malin and then decalcified in EDTA. Paraffin-embedded
sections were stained with toluidine blue for assessment
of synovial inflammation, cartilage degradation and sub-
chondral bone erosion [13,14]. Number of osteoclasts
was evaluated by tartrate-resistant acid phosphatase
(TRAP) staining of embedded sections. All analyses were
performed using a Zeiss Observer.Z1 and an image ana-
lysis system (Zeiss AxioVision 4.8. software; Carl Zeiss,
Marburg, Germany).
Human synovial tissues
Samples of synovial tissues from patients with RA or
osteoarthritis (OA) (according to the 1987 revised
American College of Rheumatology criteria for RA and
OA) were obtained at joint replacement surgery. All
patients gave written consent and the studies were
approved by the ethics committees of the ‘Ärztekammer
Westfalen-Lippe; and of the Medical Faculty of the
Westfälische Wilhelm-University Muenster.
Human and mouse fibroblasts
Human and mouse SF were isolated by enzymatic diges-
tion of synovial tissues and hind paws, respectively. All
cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) with 10% fetal calf serum (FCS) at
37°C and 5% CO2. Human and murine SF were used
until passages 4.
Immunohistochemical and immunofluorescence staining
For immunohistochemistry, paraffin-embedded sections
were pretreated with Trypsin/EDTA for 15 min at 37°C,
blocked with 5% horse serum and stained with rabbit
anti-human FAPalpha antibodies (Abcam, Cambridge,
MA, USA) or rabbit immunoglobulin G (IgG). Detectionwas performed with an alkaline phosphatase technique
(Vectastain, Vector Laboratories, Burlingame, CA, USA).
Methyl green was used for counterstaining (Vector
Laboratories).
For immunofluorescence staining, human fibroblasts
were fixed and permeabilized with 4% PFA, washed and
quenched with 0.1 M NH4Cl. After blocking with 2% horse
serum, cells were stained with anti-human FAPalpha anti-
bodies and labeled by a secondary AlexaFluor488 antibody
(Life Technologies, Darmstadt, Germany). Nuclei were
stained using DAPI, the cytoskeleton using phalloidin.
RT-PCR and genotyping
cDNAs were synthesized from total RNAs obtained from
OASF and RASF by reverse-transcriptase. FAP was amp-
lified by polymerase chain reaction (PCR) using Taq
polymerase (Peqlab) and the following primer: human
FAP forward GTTATTGCCTATTCCTATTATG; reverse
GTCCATCATGAAGGGTGGAAA [9]; glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) served as control
[15]. Genomic DNA was isolated from ear stamps and
used for genotyping of FAP-deficient mouse strains using
the REDExtract-N-Amp™ Tissue PCR Kit (Sigma-Aldrich,
St Louis, MO, USA) and the following primer: FAP forward
GGAAGACAAGGTGTATCTGTGG; reverse GTGTTTT
CTGCTACTTGAGAATAATCGG; neomycin cassette
forward GGCCATTGAACAAGATGGAT; reverse GTA
GCCGGATCAAGCGTATG.
In vitro migration assay
To assess migration of SF in vitro, a wound-healing
assay was used (ibidi, Martinsried, Germany). 2.5 × 104
SF were seeded in two cell culture reservoirs each, which
were separated by a 500 μm thick wall. After removal of
the silicone insert from the surface, closure of the created
cell-free gap (wound) by cell migration was quantified.
In vitro attachment assay
For attachment analyses, cartilage of the femoral head of
4- to 6-week-old wild-type (wt) mice was obtained asep-
tically. 6 × 104 SF were seeded onto pretreated cartilage
(1 ng/ml for 24 h) for 2 h under continuous rotation.
Following further 12 h of incubation, cartilage and attached
cells were fixed in 4.0% formalin, stained with hematoxylin
and the numbers of attached SF were across the whole
cartilage surface were counted [14].
Statistical analysis
Data are presented as means ± standard error of the
mean (SEM). Differences between two independent
groups were analyzed by the Mann–Whitney test. A
value of less than P <0.05 was considered statistically
significant.
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FAP is highly expressed in RA synovial tissues and
fibroblasts
To assess whether FAP may be involved in the pathology
of RA, we first investigated whether a higher expression
of FAP in synovial tissues as well as in SF of RA patients
is evident. Indeed, we observed a high expression of FAP
in RA throughout the whole synovial membranes. In
contrast, only marginal expression, predominantly in
the lining layer, was detectable in synovial tissues from
OA patients that were used as non-inflamed controls
(Figure 1A and B). In line with these data, SF obtained
from RA patients demonstrated a higher expression of
FAP transcripts compared to SF from OA patients
(Figure 1F) and a higher expression was observed in
RASF compared to OASF, as reflected by significantly
higher fluorescence levels (Figure 1C and D). Moreover,
FAP was localized to protrusive membrane structures of
RASF (Figure 1E).Figure 1 Expression of fibroblast activation protein (FAP) in RA. (A) Im
with osteoarthritis (OA; n = 4) and rheumatoid arthritis (RA; n = 4). Counterstai
positivity presented as percentage of positive stained area of synovial tissue. (
synovial fibroblasts (RASF, n = 3) by immunofluorescence staining; green: FAP
intensity per cell (n = 12, three independent patients). (E) Magnified section fr
(white arrows). (F) Identification of human FAP mRNA transcripts in OASF and
phosphate dehydrogenase (GAPDH) served as control.FAP deficiency does not affect clinical symptoms of
arthritis
To investigate a possible role of FAP in the pathology of
arthritis, FAP-deficient hTNFtg mice were compared
with hTNFtg mice. As expected, hTNFtg mice spontan-
eously developed an inflammatory arthritis between
week 6 and 12, which clinically presented as progressive
increase in paw swelling and loss in grip strength and
morphometrically by joint destruction (Figure 2). Sur-
prisingly, FAP-deficiency in hTNFtg mice did not lead
to significant reduction of signs of arthritis as com-
pared to hTNFtg mice. In detail, body weight was lower
in fap−/− hTNFtg than in hTNFtg mice and did not
gradually increase over time in both genotypes. Add-
itionally, grip strength decreased and paw swelling
increased during the progression of the disease, again
displaying no differences between the two genotypes.
No clinical signs of arthritis were observed in fap−/−
mice (Figure 2A).munohistochemical staining of FAP (red) in synovial tissues of subjects
ning was methyl green. Scale bars, 200 μm. (B) Quantification of FAP
C) Expression of FAP in OA synovial fibroblasts (OASF, n = 3) and RA
, red: actin cytoskeleton, blue: nucleus. (D) Quantification of fluorescence
om (C) showing localization of FAP at membrane protrusions of RASF
RASF by RT-PCR; #1-4 indicate independent patients. Glyceraldehyde-3-
Figure 2 Effect of fibroblast activation protein (FAP) deficiency on disease severity in arthritic mice. (A) Effect of FAP-deficiency on weight,
grip strength, and paw swelling over time (weeks 6 to 12). All data are means ± standard error of the mean (SEM) of 7 FAP knockout (fap−/−), 13 human
tumor necrosis factor alpha transgene (hTNFtg) and 13 (fap−/− hTNFtg) mice (B) Representative microphotographs of toluidine blue-stained joint
sections at week 12 of fap−/−, hTNFtg, and fap−/−/ hTNFtg mice, illustrating inflammation and joint destruction. (C) Magnified representative cartilage
areas, demonstrating destained cartilage caused by proteoglycan loss (arrows). (D) Tartrate-resistant acid phosphatase (TRAP) staining of corresponding
joint sections, illustrating the presence of osteoclasts (red-brownish). Scale bars, 200 μm. (E) Quantitative histomorphometric assessment of synovial
inflammation, bone erosion, cartilage degradation, and osteoclast numbers in tarsal joints. All data are means ± SEM of 7 fap−/−, hTNFtg, and fap−/−
hTNFtg mice each (*P <0.05, **P <0.01). (F) Representative genotyping PCR for confirmation of FAP deficiency in the various mouse lines.
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In order to investigate the impact of FAP on TNF-
mediated joint destruction, we next analyzed whether
the lack of FAP leads to altered histological changes in
the arthritic joints of hTNFtg mice (Figure 2B). Histo-
morphometric analyses of hind paws demonstrated that
fap−/− hTNFtg mice displayed similar synovial inflamma-
tion and bone erosion compared to hTNFtg mice, which
was accompanied by equal number of osteoclasts in the
inflamed joints (Figure 2D and E). Interestingly, FAP
deficiency ameliorated cartilage damage in the arthritic
joints, as demonstrated by significantly increased cartilage
area (about 30%) and proteoglycan content, displayed by a
significant decrease in destained cartilage by about 45%
(Figure 2C and E).
FAP deficiency reduces SF adhesion but not migration
We next investigated the influence of FAP on fibroblast
migration because SF have been implicated in inflamma-
tory cartilage degradation (Figure 3A). Surprisingly, we
observed no differences in the migration capacity of SFneither from wt and fap−/− mice nor from hTNFtg and
fap−/− hTNFtg mice during the whole time course of
56 hours (Figure 3B). However, we found a significantly
reduced attachment capacity of FAP-deficient SF to
cartilage (Figure 3C). Fap−/− hTNFtg SF demonstrated
less adhesion of about 40% compared to hTNFtg SF,
independent of whether the cartilage was pretreated with
interleukin 1 beta ( IL-1ß) or not, indicating a role for
FAP in SF adhesion to cartilage matrix (Figure 3D).Discussion
The progressive joint destruction in RA is considered to
be mediated by aggressive, tumor-like SF that invade
and destroy adjacent cartilage and bone. Migration and
invasion of cells, particular tumor cells, rely on specialized
structures called invadopodia, containing adhesion mole-
cules and proteases responsible for extracellular matrix
(ECM) degradation. Since the formation of invadopodia-
like structures by arthritis SF has been associated with
cartilage degradation [10] and additionally, FAP has been
Figure 3 Functional role of fibroblast activation protein (FAP) on synovial fibroblast behavior. (A) Micophotographs of in vitro migration
assays from human tumor necrosis factor alpha transgene (hTNFtg) and FAP knockout (fap−/−) hTNFtg SF demonstrating gap closure after 56 hours.
(B) Quantification comparison of gap closure between wild-type (wt) and fap−/− as well as hTNFtg and fap−/− hTNFtg SF at indicated time points. All
data are means ± standard error of the mean (SEM) of three mice each. (C) Representative pictures of in vitro attachment of hTNFtg and fap−/− hTNFtg
SF on wt cartilage, pretreated with 1 ng/ml interleukin 1 beta (IL-1β), after 14 hours. Cartilage and attached cells were stained with hematoxylin.
(D) Quantitative assessment of attached synovial fibroblasts (SF) from hTNFtg and fap−/− hTNFtg mice on both non-treated (white bars) and treated
(black bars) wt cartilage. All data are means ± SEM of three mice each (*P <0.05).
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pression of FAP in RA. A higher expression of FAP in the
rheumatoid synovium as well as an increased expression
by rheumatoid arthritis synovial fibroblasts (RASF) com-
pared to OA led us to the hypothesis that increased FAP
expression promotes matrix degradation in RA. To ad-
dress this question, we investigated the influence of FAP-
deficiency on joint destruction in the hTNFtg mouse
model of RA. Analysis of the arthritic changes in these
mice revealed that the lack of FAP had no effect on syn-
ovial hyperplasia and bone destruction in hTNFtg mice.
Moreover, osteoclast numbers were equal in both geno-
types, suggesting no involvement of FAP in inflammatory
osteoclast development as well as bone erosion. Moreover,
most strikingly, FAP deficiency broadly ameliorated cartil-
age degradation in hTNFtg mice, pointing to an important
role of FAP in cartilage destruction in RA.Although the proteolytic activity of FAP has been linked
to migration, we did not observe any effects of FAP on
the migratory activity of SF, pointing to a proteolytic-
independent role of FAP in cartilage degradation. In this
regard, attachment of synovial cells, particularly SF, to the
cartilage matrix has shown to be an early event in the
course of arthritis, contributing to matrix degradation
[14]. Thus, our finding that adhesion of hTNFtg SF to wt
cartilage was strongly reduced about 40% in the absence
of FAP, strongly suggests that FAP has a considerable
function in cell-matrix interaction and that this function is
independent of its proteolytic activity.
Recently, Ospelt and colleagues demonstrated that
inhibition of the dipeptidylpeptidase activity of both
FAP and DPP-4 (DPP-4-like activity) led to increased
cartilage invasion by rheumatoid arthritis SF. Interest-
ingly, increased invasion appears to be mediated by
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[11]. In addition to its dipeptidylpeptidase and gelatinoly-
tic activity, FAP is known to interact with various cell
surface molecules such as integrins and specific MMPs
which interaction is not affected by inhibition of DPP4-
like activity. In this context and of particular importance,
the formation of a complex composed of integrin α3β1
and FAP on the cell surface has been demonstrated to be
necessary for the formation of functional invadopodia on
melanoma cells [16]. Moreover, this complex appears to
be important not only for migration but also for adhesion,
and that independently of the enzymatic activity of FAP
[17]. In this context, a variety of integrins, especially those
of the β1 family, have been found to be overexpressed in
RASF [18,19] and it has been shown that blocking these
integrins on the surface of RASF reduces their attachment
and invasive capacity [20,21]. Thus, in the study by Ospelt
and colleagues, the remaining adhesion capacity of the
RASF together with the remaining gelatinase activity of
FAP and the increased expression of MMPs probably
contributed to the higher invasiveness of the RASF,
whereas blocking the formation of integrin-FAP complexes
on the surface of RASF in our study appears to account
for decreased cartilage damage.Conclusions
Our study points to a so far unknown role of FAP in
fibroblast-mediated cartilage degradation in arthritis.
While the exact nature of the matrix molecules that are
responsible for SF attachment remains to be determined,
it appears for the first time that, in addition to integrins,
FAP is involved prominently in fibroblast attachment and
cartilage degradation. It is most likely that high expression
of FAP and β1 integrins on arthritis SF leads to increased
attachment of SF to cartilage matrix, thus promoting
cartilage degradation.
Since the loss of articular cartilage is of particular import-
ance because it is largely irreversible and thus constitutes a
‘point of no return’ in the destruction of RA joints, further
understanding of the function of FAP may give rise to FAP
as a potential target for countering cartilage degradation.
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